Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies.

per Gras, L., Gilbert, R. E., Wallon, M., Peyron, F., Cortina-Borja, M.
Publicat 2004

Impact of Spiramycin Treatment and Gestational Age on Maturation of Toxoplasma gondii Immunoglobulin G Avidity in Pregnant Women

per Lefevre-Pettazzoni, M., Bissery, A., Wallon, M., Cozon, G., Peyron, F., Rabilloud, M.
Publicat 2007

Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis.

per Binquet, C., Wallon, M., Quantin, C., Kodjikian, L., Garweg, J., Fleury, J., Peyron, F., Abrahamowicz, M.
Publicat 2003

A switch towards Th2 during serological rebound in children with congenital toxoplasmosis

per Kahi, S, Cozon, G J N, Pinon, J M, Greenland, T, Wallon, M, Al Kurdi, M, Ferrandiz, J, Peyron, F
Publicat 1999

Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol.

per Gilbert, R., Dunn, D., Wallon, M., Hayde, M., Prusa, A., Lebech, M., Kortbeek, T., Peyron, F., Pollak, A., Petersen, E.
Publicat 2001